SPRC
SPRC
NASDAQ · Pharmaceuticals

Scisparc Ltd

$0.43
-0.08 (-16.29%)
Financial Highlights (FY 2026)
Revenue
45.69M
Net Income
-650,122,495
Gross Margin
73.7%
Profit Margin
-1,422.8%
Rev Growth
-14.1%
D/E Ratio
0.08
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 73.7% 73.7% 57.0% 57.0%
Operating Margin -978.3% -880.4% 34.2% 35.2%
Profit Margin -1,422.8% -1,351.6% 31.3% 33.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 45.69M 53.19M 1.35M 1.33M
Gross Profit 33.68M 39.20M 772.6K 759.7K
Operating Income -447,007,807 -468,288,937 463.6K 468.3K
Net Income -650,122,495 -681,073,501 424.2K 446.9K
Gross Margin 73.7% 73.7% 57.0% 57.0%
Operating Margin -978.3% -880.4% 34.2% 35.2%
Profit Margin -1,422.8% -1,351.6% 31.3% 33.6%
Rev Growth -14.1% -14.1% -3.8% +21.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 56.8K 56.8K 970.1K 740.6K
Total Equity 676.1K 676.1K 893.1K 867.5K
D/E Ratio 0.08 0.08 1.09 0.85
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -434,518,128 -480,493,797 830.6K 717.6K
Free Cash Flow — — 355.4K 299.5K